Skip to main content
. 2021 Jan 5;7:5. doi: 10.1038/s41531-020-00145-8

Table 2.

Irritable bowel syndrome (IBS) diagnosis and risk of Parkinson’s disease (PD), nationwide case-control analysis.

PD cases Controls Model 1a Model 2b
N N OR (95% CI) OR (95% CI)
Non-IBS 56,311 (99.6) 1,691,716 (99.7) 1 1
IBS 253 (0.4) 5204 (0.3) 1.46 (1.29–1.66) 1.44 (1.27–1.63)
Years before index date
<5 93 (0.2) 2105 (0.1) 1.33 (1.08–1.64) 1.31 (1.06–1.61)
≥5 160 (0.3) 3099 (0.2) 1.55 (1.32–1.82) 1.53 (1.30–1.79)
<10 166 (0.3) 3331 (0.2) 1.50 (1.28–1.75) 1.47 (1.26–1.72)
≥10 87 (0.2) 1873 (0.1) 1.40 (1.13–1.73) 1.38 (1.11–1.71)
Age at IBS diagnosis, years
<50 28 (0) 766 (0) 1.10 (0.75–1.60) 1.09 (0.74–1.58)
≥50 225 (0.4) 4438 (0.3) 1.52 (1.33–1.74) 1.50 (1.31–1.72)
Stratified by sex
Male 89 (0.2) 1789 (0.1) 1.49 (1.21–1.85) 1.47 (1.19–1.82)
Female 164 (0.3) 3415 (0.2) 1.44 (1.23–1.69) 1.42 (1.22–1.67)
Stratified by age on the index date, years
<70 80 (0.1) 1538 (0.1) 1.57 (1.25–1.96) 1.55 (1.24–1.94)
70–79 101 (0.2) 2184 (0.1) 1.39 (1.14–1.70) 1.36 (1.12–1.67)
≥80 72 (0.1) 1482 (0.1) 1.46 (1.15–1.85) 1.44 (1.13–1.82)

aConditional on birth year and sex.

bAdditionally adjusted for country of birth, highest achieved education, chronic obstructive pulmonary disease (COPD), comorbidity index.